We are ✨incredibly proud✨ to be leading the #TRANSFORM prostate cancer screening trial in collaboration with our colleagues from UCL Queen Mary University of London The ICR The Royal Marsden NHS Foundation Trust Imperial College London supported by Prostate Cancer UK NIHR Research Movember UK

Researchers, led by Queen Mary University of London, have identified over 2,000 genetic signals, including 113 new regions, linked to blood pressure in a study of over one million people.
Viking Genes volunteer data was part of the study.
👇
nature.com/articles/s4158…

#Hypertension #VolunteerData

Shut it down.

Stop arming Israel.

Boycott Israeli universities.

Stand with Nadera.

Free Palestine.

📢 A new national trial led by researchers Imperial NHS 💙 and Imperial College London with UCL Queen Mary University of London The ICR will recruit thousands across the UK to find the best way to screen for prostate cancer and potentially save thousands of lives.

➡️ imperial.nhs.uk/about-us/news/…

Prostate Cancer UK 1/

We're proud to announce that QMUL will be one of six lead researchers on @ProstateCancerUK's £42 million TRANSFORM screening trial.

It's the biggest and most ambitious prostate cancer trial in 20 years that will aim to transform diagnosis.

Learn more: bit.ly/3UHjjAX

#IStandWithNadera

Queen Mary University of London

#IStandWithNadera

Queen Mary University of London

#IStandWithNadera

Queen Mary University of London

#IStandWithNadera

Queen Mary University of London

#IStandWithNadera
Queen Mary University of London

#IStandWithNadera

Queen Mary University of London

#IStandWithNadera

Queen Mary University of London

#IStandWithNadera

Queen Mary University of London

#IStandWithNadera

Queen Mary University of London

#IStandWithNadera

Queen Mary University of London

#IStandWithNadera

Queen Mary University of London

#IStandWithNadera

Queen Mary University of London

#IStandWithNadera

Queen Mary University of London

#IStandWithNadera

Queen Mary University of London